Phenotype markers and cytokine intracellular production by CD8+ γδ T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls

Immunology Letters

Volumn 129, Issue 2, 2010, Pages 57-63

  Clemente, Antonio ^a   Cambra, Ana ^a   Munoz Saá, Iván ^a   Crespí, Catalina ^a   Pallarés, Lucio ^a   Juan, Antonio ^b   Matamoros, Núria ^a   Julià, Maria Rosa ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

Author keywords

T lymphocytes; Beh et's disease; CD8; Intracellular cytokines; T regulatory cells

Indexed keywords

CD103 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BEHCET DISEASE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE COUNT; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE;

ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REFERENCE STANDARDS; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 77949568734     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.02.005     Document Type: Article

References (44)

1. Mendes D., Correia M., Barbedo M., Vaio T., Mota M., Gonçalves O., et al. Behçet's disease-a contemporary review. J Autoimmun 2009, 32:178-188.
2. Seonghyang S. Etiopathology of Behçet's disease: Herpes Simplex Virus infection and animal model. Yonsei Med J 1997, 38:359-364.
3. Verity D.H., Wallace G.R., Vaughan R.W., Stanford M.R. Behçet's disease: from hippocrates to the third millennium. Br J Ophthalmol 2003, 87:1175-1183.
4. Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005, 4:81-83.
5. Verity D.H., Marr J.E., Ohno S., Wallace G.R., Stanford M.R. Behçet's disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999, 54:213-220.
6. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995, 373:255-257.
7. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., O'Brien R.B. γδ T cells: an important source of IL-17. Curr Opin Immunol 2008, 20:353-357.
8. Raga S., Julià M.R., Crespí C., Figuerola J., Martínez N., Milà J., et al. Gammadelta T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-alpha and IFN-gamma-producers in response to Pseudomonas aeruginosa. Respir Res 2003, 4:9. [Epub 2003 September 8].
9. Carding S.R., Egan P.L. γδ T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002, 2:336-345.
10. Harrinson L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996, 184:2167-2174.
11. + γδ T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen. Transplant Int 2008, 21:679-687.
12. Ashour H.M., Niederkorn J.Y. γδ T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J Immunol 2006, 177:8331-8337.
13. Locke N.R., Stankovic S., Funda D.P., Harrison L.C. TCRγδ intraepithelial lymphocytes are required for self-tolerance. J Immunol 2006, 176:6553-6559.
14. δ1 gene segment. Eur J Immunol 1991, 21:1053-1059.
15. Peng G., Wang H.Y., Peng W., Kiniwa Y., Heon Seo K., Wang R. Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique Toll-like receptor signaling pathway. Immunity 2007, 27:334-348.
16. + intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest 2008, 118:281-293.
17. Yamashita N., Kaneoka H., Kaneko S., Takeno M., Oneda K., Koizumi H., et al. Role of γδ T lymphocytes in the development of Behçet's disease. Clin Exp Immunol 1997, 107:241-247.
18. Verjans G.M., van Hagen P.M., van der Kooi A., Osterhaus A.D., Baarsma G.S. Vγ9Vδ2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 2002, 130:46-54.
19. Hamzaoui K., Hamzaoui A., Hentati F., Kahan A., Ayed K., Chabbou A., et al. Phenotype and functional profile of T cells expressing γδ receptor from patients with active Behçet's disease. J Rheumatol 1994, 21:2301-2306.
20. Freysdottir J., Lau S., Fortune F. γδ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999, 118:451-457.
21. Suzuki Y., Hoshi K., Matsuda T., Mizushima Y. Increased peripheral blood γδ T cells and natural killer cells in Behçet's disease. J Rheumatol 1992, 19:588-592.
22. Bank I., Duvdevani M., Livneh A. Expansion of γδ T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003, 141:33-41.
23. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
24. Bhakta B.B., Brennan P., James T.E., Chamberlain M.A., Noble B.A., Silman A.J. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology 1999, 38:728-733.
25. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
26. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., et al. Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 2001, 167:5527-5530.
27. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
28. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaría P., Bluestone J.A., et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004, 20:757-767.
29. Groh V., Brühl A., El-Gabalawy H., Nelson J.L., Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 2003, 100:9452-9457.
30. O'Garra A., Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004, 10:801-805.
31. - regulatory T cells. Proc Natl Acad Sci USA 2002, 99:13031-13036.
32. 7(βp) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur J Immunol 1991, 21:2591-2597.
33. Moebius U., Kober G., Griscelli A.L., Hercend T., Meuer S.C. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol 1991, 21:1793-1800.
34. Lambert C., Genin C. CD3 bright lymphocyte population reveal γδ T cells. Cytometry B: Clin Cytom 2004, 61:45-53.
35. Hüe S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21:367-377.
36. Setty M., Hormaza L., Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther 2008, 12:289-298.
37. Curnow S.J., Pryce K., Modi N., Knight B., Graham E.M., Stewart J.E., et al. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?. Immunol Lett 2008, 121:7-12.
38. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine environment in active Behcet's uveitis. Am J Ophthalmol 2006, 142:429-434.
39. Munoz-Saá I., Cambra A., Pallarés L., Espinosa G., Juan A., Pujalte F., et al. Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behçet's disease. Scand J Immunol 2006, 64:77-82.
40. + T regulatory cells. Curr Opin Immunol 2008, 20:327-331.
41. Pons J., Sauleda J., Ferrer J.M., Barceló B., Fuster A., Regueiro V., et al. Blunted γδ T-lymphocyte response in chronic obstructive pulmonary disease. Eur Respir J 2005, 25:441-446.
42. + T cells with regulatory properties from human blood. J Exp Med 2001, 193:1303-1310.
43. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002, 196:1335-1346.
44. + regulatory T cell activity in both humans and mice. J Immunol 2004, 172:834-842.